Xtant Medical Holdings
XTNT
19 hedge funds and large institutions have $54.1M invested in Xtant Medical Holdings in 2022 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 2 closing their positions.
769% more capital invested
Capital invested by funds: $6.22M → $54.1M (+$47.8M)
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
100% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 2
6% more funds holding
Funds holding: 18 → 19 (+1)
17.53% less ownership
Funds ownership: 92.91% → 75.38% (-18%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$105K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$28.5K |
| 3 |
Millennium Management
New York
|
+$16.9K |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$13.8K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$883 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$13.7K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$9K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$564 |
XTNT Hedge Fund Activity: Q4 2022 in Review
19 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Xtant Medical Holdings (XTNT) for Q4 2022, worth a combined $54.1M — up 769% from $6.22M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new XTNT positions and 2 closed out — a net gain of 2 holders — while 4 added to existing stakes and 2 trimmed.
The largest buyer was Vanguard Group, adding an estimated $105K. The largest seller was Renaissance Technologies, cutting an estimated $13.7K.
- 19 institutional investors held Xtant Medical Holdings (XTNT) as of Q4 2022, up from 18 in Q3 2022.
- Funds reported $54.1M of Xtant Medical Holdings stock for Q4 2022, up 769% quarter-over-quarter.
- 4 funds opened new Xtant Medical Holdings positions in Q4 2022 and 2 closed out, a net change of +2 holders.
- The largest Xtant Medical Holdings buyer in Q4 2022 was Vanguard Group, an estimated $105K added.
- The largest Xtant Medical Holdings seller in Q4 2022 was Renaissance Technologies, an estimated $13.7K sold.
Based on aggregated 13F filings for Q4 2022.